Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Merck Announces Exit Of Dr. Julie L. Gerberding, Chief Patient Officer & Executive VP Population Health & Sustainability – $MRK $DIA

By John F. Heerdink, Jr.

Reportedly, Merck & Co., Inc. (MRK) chief patient officer and executive vice president, population health and sustainability, Dr. Julie L. Gerberding, to retire from the company in May 2022. Dr. Gerberding to join as CEO of the Foundation for the National Institutes of Health (FNIH) on May 16.

“Julie’s accomplishments during her 12 years with Merck will have an impact on our company, our communities, and the patients we serve that extends well beyond her tenure with us. Julie embraced and embodied Merck’s commitment to patients and to our purpose to save and improve lives. Julie has been instrumental in developing our environmental, social, and governance strategy, which will enable Merck to continue our exemplary legacy of being a force for good in the world. I am grateful to her for her leadership and for her many contributions to our company and global health,” stated Robert M. Davis, chief executive officer and president, Merck.

Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the leading edge of research. Merck has the industry’s largest immuno-oncology clinical research program. To learn more about Merck (MRK) and to track its ongoing progress please visit the Vista Partners Merck Coverage Page.

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 

Stay Informed! Stay Competitive! Please join us at Vista Partners to receive our FREE email updates throughout the week and view our exclusive content and research. Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

(Read Original Story: Dr. Julie L. Gerberding to Retire from Merck in Business Wire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us